EspañolChineseOther languages

 
HomeAbout UsIn The NewsMediaContact UsDonateAdvocateWalkShopAction Center

24/7 Helpline:

800.272.3900

Find us anywhere

New York City Chapter

The Science of Alzheimer's Text Size controls Normal font sizeIncrease font size PrintEmail  
     
 

Chapter Friends and Supporters
Meet Leading Scientists



2008   2009
A New Genetic Risk Factor for Alzheimer’s Disease
  • Peter Davies, PhD, Albert einstein College of Medicine, litwin-Zucker Center for research on Alzheimer’s Disease, North Shore/lIJ Health Care System, and
  • Philippe Marambaud, PhD, lIJ Medical Center research Institute
Early Diagnosis: The Path to Alzheimer’s Disease Prevention
  • Mony de Leon, PhD, Center for Brain Health, New York University School of Medicine, and
  • Lisa Mosconi, PhD, MS, New York University School of Medicine
Redirecting Traffic: A New Look at an Old Problem in Alzheimer’s Disease
  • Richard Mayeux, MD, Taub Institute for research on Alzheimer’s Disease and the Aging Brain, Columbia University, and
  • Scott A. Small, MD, Columbia University, School of Physicians and Surgeons

  Developing New Treatments for Alzheimer’s Disease
  • Mary Sano, PhD, Alzheimer’s Disease research Center, Mount Sinai School of Medicine, and
  • Hillel Grossman, MD, Alzheimer’s Disease research Center, Mount Sinai School of Medicine, Mount Sinai Memory and Aging Center
The Role of the Alzheimer’s Amyloid Beta Protein in the Innate Immune System
  • Rudolph E. Tanzi, PhD, Harvard Medical School, Genetics and Aging research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, and
  • Robert D. Moir, PhD, Harvard Medical School, Genetics and Aging research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital
Update on Early Diagnosis and Prevention
  • Steven H. Ferris, PhD, Alzheimer’s Disease Center, Center of excellence on Brain Aging, New York University langone Medical Center Vaccination for Alzheimer’s Disease
  • Thomas M. Wisniewski, MD, New York University School of Medicine
The Amyloid Hypothesis of Alzheimer’s — An Update for 2010
  • Sam Gandy, MD, PhD, Mount Sinai School of Medicine
Dimebon, a Promising Alzheimer’s Drug, Elevates Brain Amyloid Levels
  • John W. Steele IV, Mount Sinai School of Medicine, Graduate School of Biological Sciences
The Cutting Edge of Alzheimer’s Research
  • Norman R. Relkin, MD, PhD, Weill Cornell Medical College, Weill Cornell Memory Disorders Program
A Ruler for Shrinking Brains
  • Dana W. Moore, PhD, Weill Cornell Medical College
 
 
 

Previous
| Next


Security & Privacy Policy Disclaimer Copyrights & Reprints About this Site Contact Us

Chapter Headquarters
New York City - 360 Lexington Avenue, 4th Floor,
New York, NY 10017 Phone 646.744.2900

National Headquarters
Alzheimer's Association National Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2012 Alzheimer's Association. All rights reserved.

24/7 Helpline: 1.800.272.3900